PAVmed PAVM

$ 0.6 -0.84%

Quarterly report 2024-Q2
added 08-12-2024

PAVmed Balance Sheet 2011-2024 | PAVM

Annual Balance Sheet PAVmed

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-15.1 M	-36.8 M	-	-2.3 M	1.92 M	-319 K	409 K	-586 K	-767 K	-839 K	-	-	-
Long Term Debt	2.96 M	1.85 M	-	300 K	-	-	1.94 M	-	-	-	-	-	-
Long Term Debt Current	1.56 M	1.14 M	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	300 K	-	-	1.94 M	-	-	-	-	-	-
Total Current Liabilities	54.2 M	41.2 M	-	-	11.9 M	11 M	2.54 M	1.19 M	-	-	-	-	-
Total Liabilities	57.1 M	43 M	7.56 M	20.3 M	11.9 M	11 M	4.49 M	1.19 M	580 K	47.2 K	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-294 M	-228 M	-139 M	-88.3 M	-53.7 M	-37 M	-17.9 M	-7.7 M	-2.05 M	-274 K	-	-	-
Total Assets	33.1 M	54 M	87 M	19.8 M	7.24 M	8.5 M	1.64 M	870 K	1.21 M	842 K	-	-	-
Cash and Cash Equivalents	19.6 M	39.7 M	77.3 M	17.3 M	6.22 M	8.22 M	1.54 M	586 K	767 K	-	-	-	-
Book Value	-24 M	10.9 M	79.4 M	-473 K	-4.64 M	-2.48 M	-2.85 M	-319 K	634 K	795 K	-	-	-
Total Shareholders Equity	-53.8 M	-9.68 M	61.7 M	1.9 M	-3.82 M	-2.31 M	-2.85 M	-319 K	634 K	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet PAVmed

	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	4.66 M	2.81 M	2.96 M	3.34 M	3.73 M	3.94 M	1.85 M	2 M	2.18 M	2.11 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	2.18 M	2.11 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	58.1 M	57.8 M	57.1 M	57.8 M	54.5 M	54.5 M	43 M	43.9 M	41 M	19.6 M	7.56 M	7.75 M	5.33 M	3.33 M	20.3 M	20.3 M	20.3 M	20.3 M	11.9 M	11.9 M	11.9 M	11.9 M	11 M	11 M	11 M	11 M	4.49 M	4.49 M	4.49 M	4.49 M	1.19 M	1.19 M	1.19 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-321 M	-310 M	-294 M	-279 M	-261 M	-246 M	-228 M	-208 M	-181 M	-156 M	-139 M	-122 M	-109 M	-97.8 M	-88.3 M	-88.3 M	-88.3 M	-88.3 M	-53.7 M	-53.7 M	-53.7 M	-53.7 M	-37 M	-37 M	-37 M	-37 M	-17.9 M	-17.9 M	-17.9 M	-17.9 M	-7.7 M	-7.7 M	-7.7 M	-2.75 M	-2.05 M	-2.05 M	-2.05 M	-2.05 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	39.4 M	37.3 M	33.1 M	42 M	53.7 M	65.3 M	54 M	72.5 M	82.5 M	84.3 M	87 M	43 M	47.4 M	51.4 M	19.8 M	19.8 M	19.8 M	19.8 M	7.24 M	7.24 M	7.24 M	7.24 M	8.5 M	8.5 M	8.5 M	8.5 M	1.64 M	1.64 M	1.64 M	1.64 M	870 K	870 K	870 K	781 K	1.21 M	1.21 M	1.21 M	1.21 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	25.5 M	25.5 M	19.6 M	26.4 M	37.2 M	49.3 M	39.7 M	56.8 M	65.2 M	64.7 M	77.3 M	37.3 M	43.2 M	48.5 M	17.3 M	17.3 M	17.3 M	17.3 M	6.22 M	6.22 M	6.22 M	6.22 M	8.22 M	8.22 M	8.22 M	8.22 M	1.54 M	1.54 M	1.54 M	1.54 M	586 K	586 K	586 K	236 K	767 K	767 K	767 K	767 K	839 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	-18.6 M	-20.6 M	-24 M	-15.8 M	-830 K	10.8 M	10.9 M	28.6 M	41.4 M	64.7 M	79.4 M	35.2 M	42 M	48 M	-473 K	-473 K	-473 K	-473 K	-4.64 M	-4.64 M	-4.64 M	-4.64 M	-2.48 M	-2.48 M	-2.48 M	-2.48 M	-2.85 M	-2.85 M	-2.85 M	-2.85 M	-319 K	-319 K	-319 K	781 K	1.21 M	1.21 M	1.21 M	1.21 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	-73.9 M	-68.8 M	-53.8 M	-43.3 M	-830 K	10.8 M	-9.68 M	28.6 M	41.4 M	64.7 M	61.7 M	35.2 M	42 M	50.3 M	1.9 M	1.9 M	1.9 M	1.9 M	-3.82 M	-3.82 M	-3.82 M	-3.82 M	-2.31 M	-2.31 M	-2.31 M	-2.31 M	-2.85 M	-2.85 M	-2.85 M	-2.85 M	-319 K	-319 K	-319 K	-63 K	634 K	634 K	634 K	634 K	795 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency